Peroxisomal beta-oxidation and steatohepatitis
- PMID: 11296696
- DOI: 10.1055/s-2001-12928
Peroxisomal beta-oxidation and steatohepatitis
Abstract
Fatty acid beta-oxidation occurs in both mitochondria and peroxisomes. Mitochondria catalyze the beta-oxidation of the bulk of short-, medium-, and long-chain fatty acids derived from diet, and this pathway constitutes the major process by which fatty acids are oxidized to generate energy. Peroxisomes are involved, preferentially, in the beta-oxidation chain shortening of very long chain fatty acids (VLCFAs) and in the process produce H2O2. Long-chain fatty acids and VLCFAs are also metabolized by the cytochrome P450 CYP4A omega-oxidation system to toxic dicarboxylic acids (DCAs) that serve as substrates for peroxisomal beta-oxidation, and this process also leads to the production of superoxide and H2O2. The genes encoding peroxisomal, microsomal, and certain mitochondrial fatty acid metabolizing enzymes in liver are transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPAR alpha). Deficiencies of the enzymes of peroxisomal beta-oxidation have been recognized as important causes of disease. Evidence from mice deficient in PPAR alpha (PPAR alpha-/-), deficient in peroxisomal fatty acyl-CoA oxidase (AOX-/-), the first enzyme of the classical beta-oxidation system, and deficient in both PPAR alpha and AOX (PPAR alpha-/-AOX-/-) points to the critical importance of PPAR alpha-inducible peroxisomal and microsomal oxidation systems that metabolize LCFAs and VLCFAs in the pathogenesis of nonalcoholic microvesicular hepatic steatosis and steatohepatitis. These and other mouse models should provide greater understanding of the molecular mechanism responsible for hepatic steatosis and steatohepatitis. Deficiency of AOX disrupts the oxidation of VLCFAs, DCAs, and other substrates leading to extensive microvesicular steatosis and steatohepatitis. Loss of this enzyme also causes sustained hyperactivation of PPAR alpha, leading to transcriptional up-regulation of PPAR alpha-regulated genes, indicating that unmetabolized substrates of AOX function as ligands of PPAR alpha. beta-Oxidation is the major process by which fatty acids are oxidized to generate energy, especially when glucose availability is low during periods of starvation. Mice deficient in PPAR alpha and those nullizygous for both PPAR alpha and AOX show a minimal steatotic phenotype under fed conditions but manifest an exaggerated steatotic response to fasting, indicating that defects in PPAR alpha-inducible fatty acid oxidation determine the severity of fatty liver phenotype to conditions reflecting energy-related stress.
Similar articles
-
Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.J Biol Chem. 1999 Jul 2;274(27):19228-36. doi: 10.1074/jbc.274.27.19228. J Biol Chem. 1999. PMID: 10383430
-
Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.Annu Rev Nutr. 2001;21:193-230. doi: 10.1146/annurev.nutr.21.1.193. Annu Rev Nutr. 2001. PMID: 11375435 Review.
-
Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.Curr Mol Med. 2003 Sep;3(6):561-72. doi: 10.2174/1566524033479537. Curr Mol Med. 2003. PMID: 14527087 Review.
-
Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.J Biol Chem. 2000 Sep 15;275(37):28918-28. doi: 10.1074/jbc.M910350199. J Biol Chem. 2000. PMID: 10844002
-
Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis.Am J Physiol Gastrointest Liver Physiol. 2001 Dec;281(6):G1333-9. doi: 10.1152/ajpgi.2001.281.6.G1333. Am J Physiol Gastrointest Liver Physiol. 2001. PMID: 11705737 Review.
Cited by
-
Identification of regulatory networks and crosstalk factors in brown adipose tissue and liver of a cold-exposed cardiometabolic mouse model.Cardiovasc Diabetol. 2024 Aug 14;23(1):298. doi: 10.1186/s12933-024-02397-7. Cardiovasc Diabetol. 2024. PMID: 39143620 Free PMC article.
-
The HuMet Repository: Watching human metabolism at work.Cell Rep. 2024 Aug 27;43(8):114416. doi: 10.1016/j.celrep.2024.114416. Epub 2024 Jul 20. Cell Rep. 2024. PMID: 39033506 Free PMC article.
-
Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice.Nutrients. 2023 Aug 29;15(17):3779. doi: 10.3390/nu15173779. Nutrients. 2023. PMID: 37686810 Free PMC article.
-
ACOX-driven peroxisomal heterogeneity and functional compartmentalization in brown adipocytes of hypothyroid rats.R Soc Open Sci. 2023 May 3;10(5):230109. doi: 10.1098/rsos.230109. eCollection 2023 May. R Soc Open Sci. 2023. PMID: 37153362 Free PMC article.
-
Protective effect of protein hydrolysates from Litopenaeus vannamei waste on oxidative status, glucose regulation, and autophagy genes in non-alcoholic fatty liver disease in Wistar rats.Iran J Basic Med Sci. 2022 Aug;25(8):954-963. doi: 10.22038/IJBMS.2022.62167.13761. Iran J Basic Med Sci. 2022. PMID: 36159326 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources